Trial quantifies quality-of-life, cost benefits of FFR-guided PCI

10/29/2012 | TheHeart.org (Montreal)

Fractional flow reserve-guided percutaneous coronary intervention is cost-effective and improves quality of life when compared with medical management in stable patients who have flow-limiting coronary lesions, according to results from the FAME II trial. Researchers found similar outcomes for rates of mortality and myocardial infarction but a significantly lower rate of urgent revascularization at the two-year mark for PCI patients.

View Full Article in:

TheHeart.org (Montreal)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI